SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Traders are closely monitoring the upcoming Federal Reserve meeting, with high expectations for a rate hike as sentiment remains bearish amid concerns over rising Treasury yields, inflation, and oil price volatility. While some participants weigh the potential impact of AI development slowdowns and ongoing geopolitical tensions on market stability, the conversation remains largely focused on the Fed's policy trajectory and its influence on broader market performance.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The community is debating the potential impacts of a Federal Reserve rate hike following reports of a 90% probability of an increase, while also reacting to conflicting signals regarding artificial intelligence development and rising Treasury yields.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as traders anticipate positive guidance updates and upcoming trial data, following recent healthcare conference appearances. Community sentiment remains bullish, with investors speculating on potential institutional accumulation and the company's long-term value driven by its TIL therapy platform.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending as traders debate whether the stock's recent price consolidation represents institutional accumulation or manipulation, with many investors maintaining a bullish long-term outlook based on fundamental growth and free cash flow despite the lack of immediate upward momentum. While some traders expressed frustration over the stock's failure to sustain rallies and its sensitivity to interest rate concerns and analyst downgrades, others highlight strong technical indicators and upcoming holiday season e-commerce tailwinds as catalysts for a potential reversal.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as traders react to rising long-term Treasury yields and shifting expectations for a potential Federal Reserve rate hike. The conversation remains divided, with some investors debating whether to buy the dip in bonds while others anticipate further downside due to ongoing inflationary pressures and energy market volatility.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is experiencing technical weakness, with traders monitoring its inability to hold key support levels and repeated failures beneath resistance zones. Sentiment is largely cautious as participants wait for upcoming Federal Reserve communications to clarify the market's direction amidst broader volatility.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech is trending as investors weigh clinical data updates on its oncology pipeline against the company's recent leadership transition, with some traders expressing disappointment over the upcoming departure of the founders while others remain optimistic about the late-stage trial catalysts.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

GoldCoin is trending as traders analyze the impact of rising US Treasury yields and shifting inflation expectations on precious metals, while observing a significant rotation of capital between gold and Bitcoin. Market discussions focus on whether the asset is a viable hedge against potential fiscal instability and national debt concerns during a period of macroeconomic uncertainty.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

Traders are actively debating the structural decay of the instrument, with many expressing frustration over its failure to track volatility spikes during periods of market stress, frequently labeling it a "scam" due to consistent performance degradation. While some investors remain bearish on the broader market and hold positions for potential tail-risk events, others warn that its design as a short-term trading tool makes long-term holding highly unprofitable.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuum's shares are experiencing volatility following its initial public offering as investors weigh the company's long-term potential in the quantum computing sector against concerns regarding its high valuation and lack of significant current revenue. While some traders are focused on the stock as a long-term play backed by strategic partners, others remain skeptical, citing broader market weakness and the company's early-stage financial profile.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
